SCHEMBL2169082

SCHEMBL2169082

NC(=O)C(CC(=O)O)N1Cc2c(N)cccc2C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
POLB P06746 1/20 0.40
ALOX15 P16050 3/20 0.40
MAPT P10636 3/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
KDM4E B2RXH2 2/20 0.37
BRD4 O60885 1/20 0.37
TNF P01375 1/20 0.37
IL1B P01584 1/20 0.37
IKZF1 Q13422 1/20 0.37
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37
IKZF3 Q9UKT9 1/20 0.37
TSHR P16473 1/20 0.34
XIAP P98170 1/20 0.34
HKDC1 Q2TB90 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7677588 0.91 ALOX15 (0.46) ALDH1A1L3MBTL1POLBALOX15MAPT
SCHEMBL501841 0.88 KDM4E (0.45) ALDH1A1L3MBTL1POLBALOX15MAPT
SCHEMBL30677181 0.88 KDM4E (0.45) ALDH1A1L3MBTL1POLBALOX15MAPT
SCHEMBL7671115 0.86 MAPT (0.41) ALDH1A1L3MBTL1POLBALOX15MAPT
SCHEMBL869453 0.85 MEN1 (0.41) ALDH1A1L3MBTL1ALOX15MAPTSMN1; SMN2
SCHEMBL7678935 0.85 MEN1 (0.43) ALDH1A1L3MBTL1POLBALOX15MAPT
SCHEMBL30009493 0.85 ALOX15 (0.41) ALDH1A1L3MBTL1POLBALOX15MAPT
SCHEMBL7679763 0.85 ALOX15 (0.45) ALDH1A1L3MBTL1POLBALOX15MAPT
SCHEMBL7680568 0.84 KMT2A (0.41) ALDH1A1L3MBTL1POLBALOX15MAPT
SCHEMBL21251502 0.84 ALDH1A1 (0.36) ALDH1A1L3MBTL1POLBALOX15MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4728487-B2 2011-07-20 JP claimed
JP-2002539197-A 2002-11-19 JP claimed
EP-1163219-A1 SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS CELGENE CORPORATION (US) 2001-12-19 EP claimed
WO-2000055134-A1 SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS CELGENE CORPORATION (US) 2000-09-21 WO claimed
US-6380239-B1 FOR THERAPY OF ARTHRITIS, RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, REPERFUSION INJURY, INFLAMMATORY BOWEL DISEASE, CROHN'S DISEASE, ULCERATIVE COLITIS, SYSTEMIC LUPUS ERYTHREMATOSIS, SCLERODERMA, APHTHOUS ULCERS, ASTHMA CELGENE CORPORATION 2002-04-30 US disclosed
EP-1163219-A1 SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS CELGENE CORPORATION (US) 2001-12-19 EP disclosed
WO-2000055134-A1 SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS CELGENE CORPORATION (US) 2000-09-21 WO disclosed